Literature DB >> 9497163

Metabolic interactions between glucose and fatty acids in humans.

R R Wolfe1.   

Abstract

In vivo energy production results largely from the oxidative metabolism of either glucose or fatty acids. Under diverse physiologic and nutritional conditions, the oxidation of either glucose or fatty acids may predominate. The nature of the control of the availability and oxidation of each substrate has been studied extensively for > or = 30 y. The most popular and enduring hypothesis was proposed by Randle et al in 1963 and is termed the glucose-fatty acid cycle. This proposal places great significance on the regulation of lipolysis as a factor controlling substrate metabolism. Our work has led to an opposite perspective, which could be called the glucose-fatty acid cycle reversed. According to our hypothesis, the rate of glycolysis, determined by the intracellular availability of glucose-6-phosphate, is the predominant factor determining the rate of glucose oxidation. Whereas the rate of lipolysis may have some effect on the availability of glucose, both via a fatty acid-mediated inhibition of plasma glucose uptake and also by supplying glycerol for gluconeogenesis, there is little evidence for a direct inhibitory effect of fatty acid oxidation on the intracellular oxidation of glucose. In contrast, increased glucose oxidation limits oxidation of long-chain fatty acids directly by inhibiting their transport into the mitochondria. Consequently, whereas there is a close coupling between glucose availability and oxidation, fatty acids are generally available in greater quantities than are required for oxidation. We propose that fatty acid oxidation is largely controlled at the site of oxidation, which is in turn determined by the availability of glucose, rather than by its availability via lipolysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497163     DOI: 10.1093/ajcn/67.3.519S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  32 in total

Review 1.  Nutritional papers in ICU patients: what lies between the lines?

Authors:  Jean-Charles Preiser; René Chioléro; Jan Wernerman
Journal:  Intensive Care Med       Date:  2002-12-21       Impact factor: 17.440

Review 2.  Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship.

Authors:  Kathryn T Kopec; Michael J Kowalski
Journal:  J Med Toxicol       Date:  2013-03

Review 3.  Exercise and Regulation of Carbohydrate Metabolism.

Authors:  Joram D Mul; Kristin I Stanford; Michael F Hirshman; Laurie J Goodyear
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-20       Impact factor: 3.622

4.  Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.

Authors:  Anna Wilk; Katarzyna Urbanska; Maja Grabacka; Jennifer Mullinax; Cezary Marcinkiewicz; David Impastato; John J Estrada; Krzysztof Reiss
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

5.  Glycemic index and glycemic load of popular weight-loss diets.

Authors:  James M Shikany; Sarah E Thomas; C Suzanne Henson; David T Redden; Douglas C Heimburger
Journal:  MedGenMed       Date:  2006-01-25

6.  Effects of acute carbohydrate supplementation during sessions of high-intensity intermittent exercise.

Authors:  Maysa Vieira de Sousa; Herbert Gustavo Simões; Marie Oshiiwa; Marcelo Macedo Rogero; Julio Tirapegui
Journal:  Eur J Appl Physiol       Date:  2006-10-06       Impact factor: 3.078

7.  Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.

Authors:  Anna Wilk; Dorota Wyczechowska; Adriana Zapata; Matthew Dean; Jennifer Mullinax; Luis Marrero; Christopher Parsons; Francesca Peruzzi; Frank Culicchia; Augusto Ochoa; Maja Grabacka; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

8.  Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.

Authors:  Jessica A Miller; Kirk Pappan; Patricia A Thompson; Elizabeth J Want; Alexandros P Siskos; Hector C Keun; Jacob Wulff; Chengcheng Hu; Julie E Lang; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-11

9.  ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.

Authors:  Justyna Drukala; Katarzyna Urbanska; Anna Wilk; Maja Grabacka; Ewa Wybieralska; Luis Del Valle; Zbigniew Madeja; Krzysztof Reiss
Journal:  Mol Cancer       Date:  2010-06-22       Impact factor: 27.401

10.  Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.

Authors:  Katarzyna Urbanska; Paola Pannizzo; Maja Grabacka; Sidney Croul; Luis Del Valle; Kamel Khalili; Krzysztof Reiss
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.